| Aleksandra D. Stanković, PhD
The Institute of Nuclear Sciences "Vinca"
Laboratory for Radiobiology and Molecular Genetics
P.O. Box 522
Born 27.11. 1964 in Belgrade.
1996. BsC thesis in Molecular biology and Phisiology, Biological faculty, University of Belgrade: »Correlation of free T4(FT4) and T4/TBG index in thyroid glan function research«.
2000. MSc Thesis in Molecular biology and Biochemistry, Biological faculty, University of Belgrade: »Association of DNA polymorphisms in angiotensin I-converting enzym gene and angiotensin II receptor gene with arterial blood pressure levels in human population«
2005. PhD Thesis in Molecular biology and Biochemistry, Biological faculty, University of Belgrade: »Molecular and epidemiological analysis of role of the renin-angiotensin system genes in urinary tract anomalies and kidney diseases«
In 1997. permanently employed in Institute of Nuclear Sciences Vinča, Laboratory for Radiobiology and Molecular genetics.
In 2005. research associate
In 2009. associate research professor
Project participation and managemant:
2011-2014. “Genetic basis of vascular and inflammatory human diseases” funded by Republic Ministry of Science and Technology, (Project OI 175085), Institute for Nuclear Sciences“VINCA”, Medical Faculty, University of Belgrade, Belgrade, Principal investigator
2011-2014. »An integral study to identify the regional genetic and environmental risk factors for the common noncommunicable diseases in the human population of Serbia« funded by Republic Ministry of Science and Technology, (Project III 41028), Institute for Nuclear Sciences“VINCA”, Belgrade, Investigator
2008-2009. “Development and application of genetic test for estimation of risk for loss of kidney function in children in Serbia” funded by Republic Ministry of Science and Technology, (Project TR 23041), Institute for Nuclear Sciences“VINCA”, University Children Hospital, Belgrade, Principal investigator
2008-2009. “Application of Radiation research and Genetic epidemiology in estimation of risk of chronic noncommunicable diseases in population of Obrenovac Municipality” funded by Republic Ministry of Science and Technology, (Project TR 23040), Institute for Nuclear Sciences “VINCA” Investigator
2005-2010. “Genetic epidemiology and pharmacogenomics of vascular diseases” funded by Republic Ministry of Science and Technology, (Project M145023), “VINCA” Institute for Nuclear Sciences, Investigator
2002- 2005. Genetic Epidemiology of Vascular Diseases, funded by Republic Ministry of Science and Technology, (Project 2011) Institute of nuclear sciences “Vinca”, (head Dr Dragan Alavantic) Investigator
1997-2000 Subproject: Genetics of cardiovasculare diseases, included in Project: Clinical and experimental research of hypertension and regulatory mechanisms, funded by the Republic Ministry of Science and Technology (13M03), 1996-2000, Institute of nuclear sciences “Vinca”, Faculty of Medicine, Belgrade (head Dr Dragan Alavantic) Investigator
1997-1998 Project: Testing and finalization of technology in production of intravenous gamaglobuline, funded by the Republic Ministry of Science and Technology (IP3-1569), 1997-1998, Institute of nuclear sciences “Vinca”, Faculty of Medicine, Belgrade (head Dr Dragan Alavantic) Investigator
2004. Baker Heart Research Institute, Department for Diabetic Complications, Melbourne, Victoria, Australia , collaboration under project: »Role of the renin-angiotensin system in ureteric and renal disorders«. Principal Investigator
2004-2006 Perticipation in: European Commission Framework Programme: Equal Project (EC4): Multi-National External Quality Assay (EQA) Programmes in Clinical Molecular Diagnostics based on Performance and Interpretation of PCR assay including dissemination and training, supported by the European Community within the FP6 programme. Principal Investigator
2008-2010. Bilateral Project Serbia-Croatia, Genetics of Multiple Sclerosis, Serbian Republic Ministry of Science and Technology . Investigator
2008. University Hospital Erlangen, Childrens and Adolescents Hospital, Erlangen, Germany, Principal Investigator
2009-2011. Bilateral Project Serbia Slovenia, Genetics of Multiple Sclerosis, Serbian Republic Ministry of Science and Technology. Investigator
Trainees: 5 BsC, 2 MSc & 2 PhD
Reviewer for SCI Journals
PUBLISHED PEER REVIEWED ARTICLES:
Total number of publications in SCI Journals: 26
Total number of abstracts presented: 67 (1 plenary lecture)
Citations: 40 in papers in SCI Journals
Stanković A, Živković M, Kostić M, Atanacković J, Krstić Z, Alavantić D. Expression profiling of the AT2R mRNA in affected tissue from children with CAKUT. Clinical Biochemistry, 43, 2010, 71-75.
Stanković A, Dincić E, Ristić S, Lovrecić L, Starcević Cizmarević N, Djurić T, Sepcić J, Kapović M, Raicević R, Peterlin B, Alavantić D, Zivković M. Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans. Multiple Sclerosis 2010, 16:533-536.
Spasojević-Dimitrijeva B, Živković M, Stanković A, Stojković Lj, Kostić M . The IL-6-174G/C polymorphism and renal scarring in children with first acute pyelonephritis. Pediatric Nephrology 2010, 25(10):2099-106.
Živković M, Stanković A, Dincić E, Popović M, Popović S, Raicević R, Alavantić D.The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR. Clinica Chimica Acta. 2009, 406(1-2):27-30.
Djurić T, Živković M, Radak Dj, Jekić Dj, Radak S, Stojković Lj, Raičević R, Stanković A, Alavantić D. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clinical Biochemistry 2008, 41(16-17):1326-1239.
Zivković M, Djurić T, Stancić O, Alavantić D, Stanković A. X-linked angiotensin II type 2 receptor gene polymorphism -1332A/G in male patients with essential hypertension. Clinica Chimica Acta 2007, 386:110-113.
Djuric T, Zivkovic M, Stankovic A, Mecanin S, Alavantic D. Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population. J Clin Lab Anal, 2005, 19(6):241-246.
Živković M, Stanković A, Alavantić D. AT1 receptor A1166C and AT2 receptor -1332A/G gene polymorphisms: efficient genotyping by single-tube PCR. J Clin Lab Anal, 2005, 19(2): 84-86.
Kostić M, Stanković A, Živković M, Peco-Antić A, Jovanović O, Alavantić D, Kruščić D. ACE and angiotensin II type 1 receptor gene polymorphisms and renal scarring in urinary bladder dysfunction. Pediatric Nephrology, 2004,19(8): 853-857.
Živković M, Stanković A, Alavantić D. Pentanucleotide TTTTA and G/A-914 DNA polymorphisms in apolipoprotein(a) promoter: genotyping by single-tube PCR. Clin Chem Lab Med, 2003, 41: 632-633.
Stanković A, Živković M, Glišić S., Alavantić D. Angiotensin II type 1 receptor gene polymorphism and essential hypertension in Serbian population, Clin Chim Acta, 2003, 372: 181-5.
Stanković A, Zivković M, Alavantić D. Angiotensin I-converting enzyme gene polymorphism in a Serbian population: a gender-specific association with hypertension. Scand J Clin Lab Invest. 2002, 62(6):469-75.
Stankovic A, Alavantic D. Rapid detection of the hypertension-associated A1166C polymorphism of the angiotensin II type 1 receptor (AGTR1).Genet Test. 2002;6(2):133-4.